University of California San Francisco
Give to UCSF<p><span>Doug Eckman works at the intersection of dual bureaucracies. As director of operations for UCSF School of Medicine, Dean’s Office at San Francisco General Hospital and Trauma Center (SFGH), Eckman must navigate both the university and the city’s Department of Public Health. Despite the complexity and perhaps because of it, Eckman loves his work.</span></p>
<p>A proposed new treatment to help HIV/AIDS patients suffering from Kaposi’s sarcoma, the most common form of cancer in people with HIV, is now one step closer to becoming a reality thanks to a program that supports promising early-stage research.</p>
<p>UCSF's Resource Allocation Program (RAP), which incorporates a single online application for 30 different research grants, is now requesting applications for the Fall 2012 Cycle.</p>
A novel virus has been identified as the possible cause of a common but mysterious disease that kills a significant number of pet snakes all over the world, thanks to research led by scientists at the University of California, San Francisco (UCSF)—and three snakes named Juliet, Balthazar and Larry.
Scientists at the UCSF-affiliated Gladstone Institutes have discovered that an FDA-approved anti-epileptic drug reverses memory loss and alleviates other Alzheimer’s-related impairments in an animal model of the disease.
The UCSF Science & Health Education Partnership's (SEP) High School Summer Internship program prepares students for college through hands-on laboratory experience alongside a mentor.
As mothers have always known, a good night’s sleep is crucial to good health — and now a new study led by a Robert Wood Johnson Foundation Health & Society Scholar at UCSF and UC Berkeley shows that poor sleep can reduce the effectiveness of vaccines.
Adults with HIV in rural sub-Saharan Africa who receive antiretroviral drugs early in their infection may reap benefits in their ability to work and their children's ability to stay in school, according to a first-of-its-kind clinical study in Uganda that compared socioeconomic outcomes with CD4+ counts — a standard measure of health status for people with HIV.
<p>Aoife O’Donovan, PhD, a Society in Science: Branco Weiss Fellow in psychiatry at the San Francisco VA Medical Center and UCSF, was presented with the Neal E. Miller New Investigator Award for 2012 by the Academy of Behavioral Medicine Research.</p>
<p>The AIDS drug Truvada, approved this week for prevention of HIV infection in uninfected people at high risk, may benefit many uninfected women whose male partners have HIV, including pregnant women, who may be at higher risk.</p>
<p>A perspective published in the <em>New England Journal of Medicine</em> this week by professors at UCSF and the Johns Hopkins University asserts that it is now possible to begin to end the AIDS epidemic by widely and strategically applying existing tools.</p>
Lennart Mucke, MD, a professor of neurology and the Joseph B. Martin Distinguished Professor of Neuroscience at UCSF who directs neurological research at the UCSF-affiliated Gladstone Institutes, has received the Khalid Iqbal Lifetime Achievement Award for his exceptional contributions to Alzheimer’s disease research.
<p>Smokers can begin loosening the tight grip of nicotine addiction by smoking low-nicotine cigarettes, without lighting up any more than they usually do, according to recent research led by long-time UCSF nicotine researcher Neal Benowitz, MD. </p>
People with lung cancer who are treated with the drug Tarceva face a daunting uncertainty: although their tumors may initially shrink, it's not a question of whether their cancer will return—it's a question of when. And for far too many, it happens far too soon.
Gladstone Institutes Senior Investigator Shinya Yamanaka, MD, PhD, a professor of anatomy at UCSF, has won the Millennium Technology Award Grand Prize, the world’s largest and most prominent technology award.
Loneliness can be especially debilitating to older adults and may predict serious health problems and even death, according to a new study by UCSF researchers.
<p>Vitamin D and calcium to prevent bone fractures in healthy, postmenopausal women does not work, at least at low supplemental doses, according to the United States Preventive Services Task Force.</p>
A new approach to drug design, pioneered by a group of researchers at UCSF and Mt. Sinai, New York, promises to help identify future drugs to fight cancer and other diseases that will be more effective and have fewer side effects.